IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 63 filers reported holding IGM BIOSCIENCES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55 | -8.3% | 6,527 | +0.8% | 0.00% | – |
| Q2 2023 | $60 | -32.6% | 6,473 | -0.3% | 0.00% | – |
| Q1 2023 | $89 | -19.1% | 6,495 | 0.0% | 0.00% | – |
| Q4 2022 | $110 | -99.9% | 6,495 | +0.1% | 0.00% | – |
| Q3 2022 | $148,000 | +27.6% | 6,489 | +0.6% | 0.00% | – |
| Q2 2022 | $116,000 | -32.9% | 6,452 | -0.3% | 0.00% | – |
| Q1 2022 | $173,000 | -8.9% | 6,470 | +0.0% | 0.00% | – |
| Q4 2021 | $190,000 | -55.4% | 6,467 | -0.2% | 0.00% | – |
| Q3 2021 | $426,000 | -34.9% | 6,481 | -17.5% | 0.00% | -100.0% |
| Q2 2021 | $654,000 | +31.3% | 7,859 | +20.9% | 0.00% | 0.0% |
| Q1 2021 | $498,000 | -13.2% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $574,000 | +19.6% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $480,000 | +1.1% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $475,000 | +87.7% | 6,500 | +44.4% | 0.00% | – |
| Q1 2020 | $253,000 | +47.1% | 4,500 | 0.0% | 0.00% | – |
| Q4 2019 | $172,000 | – | 4,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 4,000 | $353,000 | 5.50% |
| Redmile Group, LLC | 3,425,455 | $302,433,000 | 3.66% |
| Artal Group S.A. | 1,200,000 | $105,948,000 | 2.27% |
| Woodline Partners LP | 540,416 | $47,713,000 | 1.26% |
| Cormorant Asset Management, LP | 600,000 | $52,974,000 | 1.26% |
| RA Capital Management | 982,723 | $86,765,000 | 1.21% |
| Logos Global Management LP | 150,000 | $13,244,000 | 1.14% |
| Baker Brothers Advisors | 3,144,892 | $277,663,000 | 1.05% |
| Ikarian Capital, LLC | 250,000 | $22,073,000 | 0.97% |
| HighVista Strategies LLC | 11,954 | $1,055,000 | 0.67% |